Earnings News
Quarterly earnings reports, revenue surprises, and EPS results from top companies. Follow earnings season with analyst estimates and post-earnings stock moves.
Garmin Shares Surge 17% on Q2 Margin Expansion and Upgraded Outlook
Garmin shares soared 17% after Q2 operating margin surged to 30.4%, prompting a valuation rerating. The company raised its 2026 EPS outlook to $10, well above consensus.
Avantor Surges 15% on Sales Beat, but Margin Concerns Persist
Avantor (AVTR) shares surged 15% after Q2 results beat estimates, but margin and cash-flow targets remained unchanged, signaling a demand reset.
Grab Holdings Slips as Q2 Profit Hurdle Dims Revenue Milestone
Grab shares slipped around 2% to $3.38 as Q2 revenue consensus of $1.0B is overshadowed by profit conversion concerns and higher incentive costs.
Sandisk Stock Plunges 55% in July as 80% Margins Face Scrutiny
Sandisk shares have tumbled 55% in July, leaving the stock at a potential discount if its 80% margins prove sustainable, but a steep price if they erode.
Amphenol Stock Jumps 7.6% on Strong Q2 Beat and Doubled CommScope EPS Outlook
Amphenol shares rose 7.6% after Q2 earnings beat estimates and the company doubled its expected EPS benefit from the CommScope acquisition to $0.30 per share.
Bloom Energy Surges on Record Q2 Revenue, Single Client Dominates
Bloom Energy shares jumped 4.3% after posting record Q2 revenue of $1.065 billion, beating estimates. A single customer accounted for 73% of revenue, highlighting concentration risk.
GE HealthCare Stock Jumps on Record Orders, Q2 Beat
GE HealthCare shares jumped 9.9% after Q2 earnings beat estimates and orders hit a record $23.9 billion. The stock rose to $70.43 premarket, though it remains 22% below its January high.
P&G Stock Drops as 2027 Strategy Reveals Major Earnings Hurdle
P&G shares declined 3% as the fiscal 2027 outlook revealed a 9.7% pre-headwind EPS increase needed to hit guidance, overshadowing an earnings beat.
Boston Stock Falls as International Sales Counter US Cardiac Weakness
Boston Scientific shares fell 5.1% as strong international sales countered a US cardiac downturn. Q2 earnings beat estimates but guidance was cut.
Lemonade Stock Tumbles 14% as Strong Revenue Growth Fails to Lift Profit Outlook
Lemonade (NYSE:LMND) shares dropped nearly 14% in premarket trading despite a 79% revenue surge, as the company held its full-year profit forecast steady, raising concerns about risk exposure and cash flow.
Humana Stock Tumbles 8% Premarket Despite Strong Q2, 2026 Outlook Signals Sharp H2 Loss
Humana shares dropped 8% premarket despite Q2 earnings and revenue beats, as the 2026 adjusted EPS floor of $9 implies a second-half loss of $8.91 per share.